Individuals Coming Off Anti-Obesity Jabs Put On Pounds Four Times Faster Than Dieters

Fresh analysis reveals that individuals who stop using popular slimming jabs like semaglutide or tirzepatide tend to recover shed pounds much more quickly than those who end traditional diet and exercise programs.

Research printed in a prominent medical journal points out that while overweight individuals frequently drop a large proportion of their body weight while undergoing treatment, the mass is regained at an estimated rate of nearly a kilo each month once they quit.

"People purchasing such treatments need to be aware of the potential of rapid weight regain when the medication concludes," cautioned researcher Dr. Susan Jebb.

This pace of recovery suggests a return to original mass within about one and a half years.

Analyzing Approaches

The analysis, which looked at 37 of trials involving thousands of patients, compared the results of these new drugs with conventional dieting.

Scientists emphasize that people who lose weight through diet and exercise usually experience a more gradual creep back—perhaps 100 grams monthly—after stopping.

Understanding the Fast Rebound

Doctors believe the way of the jabs accounts for the heightened rebound.

The injections copy a natural hormone called GLP-1, which moderates appetite.

"Long-term administration of the hormone levels far above than normal may cause the body to generate a reduced amount of its own natural hormone, and could lessen sensitivity to its effects," noted Dr. Adam Collins, a dietetics researcher.

"Stopping of this hormone supplement leads to hunger is uncontrolled, making excessive eating much more probable."

A Lifelong Disease?

The NHS advise the injections for people with weight-linked health risks, alongside prescribed diet and exercise modifications.

Many experts argue that, considering the significant potential of relapse, the treatment should be considered life-long.

This view is reinforced by pharmaceutical companies, who note that the findings "emphasize the persistent character of excess weight," similar to managing diseases like high blood pressure.

User Testimonies

Individuals who have come off the jabs describe a intense resurgence of hunger.

"It felt as if a switch activating and I was suddenly extremely hungry," said an individual.

The struggle is compounded if users have not developed lasting lifestyle or habit modifications during treatment.

Widespread Use

Survey data suggest that a significant number of people in the UK have tried weight-loss jabs in the last 12 months, with desire remaining high.

• Use is greater among women compared to men.
• The middle-aged demographic shows the highest level of interest.
• Many access the medications through private healthcare rather than the NHS.

Finally, researchers caution that while these medications are potent agents for shedding pounds, they are not a standalone cure and maintained weight loss likely depends on ongoing lifestyle support.